Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by beenthereon Jul 29, 2024 9:50pm
200 Views
Post# 36153653

RE:RE:RE:Update to the clinical study coming next week

RE:RE:RE:Update to the clinical study coming next week

Looks good on TLT Management!

Why giving this " selective " disclosure  to the favourite few?

Not the first time this has happened!

I at least twice registered for emails twice maybe three.

But no luck !    So the chances their system is screwed up!!

SO fix it!  How??


By just putting out a news release to all!

Too simple!

For all of their shareholders left in the dark what do you think?

I for one think I would not support this company any further!

And I think I stand for a lot of investors or we wouldn' been in this position!


As with every single company their Management is responsible!

SO what are you going to do about it?

Flub along as you have and go backrupt 

<< Previous
Bullboard Posts
Next >>